qbeco
Peptideexperimental
Clinical trial activity
4 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
4
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2013 (NCT01809275)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- qbeco
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05677113 | Phase 2 | Aug 30, 2023 | University of Toronto |
| NCT03472690 | Phase 2 | Jun 25, 2018 | Qu Biologics |
| NCT02426372 | Phase 2 | Jul 1, 2015 | Qu Biologics |
| NCT01809275 | Phase 1/Phase 2 (Phase 2) | Mar 1, 2013 | Qu Biologics, University of British Columbia |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Qu Biologics | For profit | 3 | 3 | 1 | 2013 |
| University of British Columbia | Academic/Hospital | 1 | 0 | 1 | 2013 |
| University of Toronto | Academic/Hospital | 1 | 1 | 1 | 2023 |
3 organizations
Page 1 / 1